Arterial stiffness is independently associated with interleukin-18 and components of the metabolic syndrome

Atherosclerosis

Volumn 209, Issue 2, 2010, Pages 337-339

  Trøseid, Marius ^a   Seljeflot, Ingebjørg ^a   Weiss, Thomas W ^a,b   Klemsdal, Tor O ^a   Hjerkinn, Elsa M ^a   Arnesen, Harald ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b WILHELMINEN HOSPITAL   (Austria)

Author keywords

Arterial stiffness; Inflammation; Interleukin 18; Metabolic syndrome; Pulse wave propagation

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 18; OMEGA 3 FATTY ACID;

ADULT; AGE; AGED; ARTERIAL STIFFNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; LETTER; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE;

EID: 77950019716     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.09.028     Document Type: Letter

References (19)

1. Stenhouwer C.D., Henry R.M., Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008, 51:527-539.
2. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735-52.
3. Haffner S.M. The metabolic syndrome: inflammation, diabetes mellitus and cardiovascular disease. Am J Cardiol 2006, 97:3A-11A.
4. Laurent S., Cockroft J., Van Bortel L., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588-2605.
5. Trøseid M., Seljeflot I., Hjerkinn E.M., et al. Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia. Diabetes Care 2009, 32:486-492.
6. Hjerkinn E.M., Abdelnoor M., Breivik L., et al. Effect of diet and/or very long chain n-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima media thickness and by pulse wave propagation in elderly men with hypercholesterolemia. Eur J Cardiovasc Prev Rehab 2006, 13:325-333.
7. Trøseid M., Arnesen H., Hjerkinn E.M., et al. Serum levels of interleukin-18 are reduced by diet and omega-3 fatty intervention in elderly high-risk men. Metabolism 2009, [E-pub July 10].
8. Hung J., McQuillan B.M., Chapman C.M., et al. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol 2005, 25:1268-1273.
9. Thorand B., Kolb H., Baumert J., et al. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg study 1984-2002. Diabetes 2005, 54:2932-2933.
10. Yamagami H., Kitagawa K., Hoshi T., et al. Associations of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol 2005, 25:1458-1462.
11. Nakamura A., Shikata K., Hiramatsu M., et al. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 2005, 28:2890-2895.
12. Tso T.K., Huang W.N., Huang H.Y., et al. Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus. Rheumatology 2006, 45:1148-1153.
13. Mallat Z., Corbaz A., Sco A., et al. Expression of IL-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001, 104:1598-1603.
14. Blankenberg S., Luc G., Ducimetiere P., et al. IL-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003, 108:2453-2459.
15. Koenig W., Khuseyinova N., Baumert J., et al. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol 2006, 26:2745-2751.
16. Espinola-Klein C., Rupprecht H.J., Bickel C., et al. Impact of inflammatory markers on cardiovascular mortality in patients with the metabolic syndrome. Eur J Cardiovasc Prev Rehab 2008, 15:278-284.
17. Cruickshank K., Riste L., Anderson S.G., et al. Aortic pulse wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function. Circulation 2006, 106:2085-2090.
18. De Silva D.A., Woon F.-P., Gan H.-Y, et al. Arterial stiffness, metabolic syndrome and inflammation amongst Asian ischaemic stroke patients. Eur J Neurol 2008, 15:872-875.
19. Rabkin S.W. The role of interleukin-18 in the pathogenesis of hypertension-induced vascular disease. Nat Clin Pract Cardiovasc Med 2009, 6:192-199.